Journal of drugs in dermatology : JDD 2008-08-01

Reticulated phototoxic eruption in a patient on long-term diltiazem therapy.

Miriam Hanson, Vesna Petronic-Rosic

Index: Journal. of. Drugs in. Dermatology. 7(8) , 792-3, (2008)

Full Text: HTML

Abstract

Diltiazem hydrochloride is a commonly prescribed medication in the treatment of cardiovascular disease. A case of diltiazem-induced hyperpigmentation in a patient after significant sun exposure is reported. The morphological appearance was reticulated and slate-gray to blue in color. The pathogenesis of the hyperpigmentation is discussed and possible treatment options are reviewed.

Related Compounds

Related Articles:

Effects of a novel formulation of fluocinonide 0.1% cream on skin barrier function in atopic dermatitis.

2011-02-01

[Journal. of. Drugs in. Dermatology. 10(2) , 171-6, (2011)]

Urticarial hypersensitivity reaction caused by temozolomide.

2010-09-01

[Journal. of. Drugs in. Dermatology. 9(9) , 1142-4, (2010)]

In vivo determination of the skin atrophy potential of the super-high-potency topical corticosteroid fluocinonide 0.1% cream compared with clobetasol propionate 0.05% cream and foam, and a vehicle.

2008-01-01

[Journal. of. Drugs in. Dermatology. 7(1) , 28-32, (2008)]

The efficacy of three class I topical synthetic corticosteroids, fluocinonide 0.1% cream, clobetasol 0.05% cream and halobetasol 0.05% cream: a Scholtz-Dumas bioassay comparison.

2009-08-01

[Journal. of. Drugs in. Dermatology. 8(8) , 751-5, (2009)]

Improvement in treatment adherence with a 3-day course of fluocinonide cream 0.1% for atopic dermatitis.

2010-10-01

[Cutis. 86(4) , 208-13, (2010)]

More Articles...